Search

Author/Creator Nowakowski, G. S

3. FIRST‐MIND: A PHASE IB, OPEN‐LABEL, RANDOMIZED STUDY TO ASSESS SAFETY OF TAFASITAMAB OR TAFASITAMAB + LENALIDOMIDE IN ADDITION TO R‐CHOP IN PATIENTS WITH NEWLY DIAGNOSED DLBCL. (17th June 2021)

Authors:
Belada, D; Kopeckova, K; Bergua Burgues, J. M; André, M; Pérez Persona, E; Pichler, P; Klöpfer, P; Brackertz, B; Lohrmann, E; Lahiry, A; Shah, N; Brugger, W; Burke, J. M; Nowakowski, G. S
Journal:
Hematological oncology
Issue:
Volume 39(2021)Supplement 2
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. IMPACT OF TIME TO RELAPSE AND RESPONSE TO SALVAGE THERAPY ON POST AUTOLOGOUS STEM CELL TRANSPLANT OUTCOMES IN RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA. (17th June 2021)

Authors:
Tun, A. M; Wang, Y; Maliske, S; Farooq, U; Micallef, I. N; Inwards, D. J; Porrata, L. F; Ansell, S. M; Rosenthal, A. C; Kharfan‐Dabaja, M; Link, B. K; Villasboas, J. C; Paludo, J; Cerhan, J. R; Habermann, T. M; Witzig, T. E; Nowakowski, G. S; Johnston, P. B
Journal:
Hematological oncology
Issue:
Volume 39(2021)Supplement 2
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search